C反応性タンパク質と亜臨床性動脈硬化症の関係: ダラス心臓研究
Amit Khera1, James A de Lemos, Ronald M Peshock
1Donald W. Reynolds Cardiovascular Clinical Research Center, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA. amit.khera@utsouthwestern.edu
Circulation
|December 29, 2005
まとめ
C反応性タンパク質 (CRP) の上昇は,心血管疾患のリスクが高いことを示します. しかし,CRPは,従来の危険因子に調整すると,関連が弱くなるため,動脈硬化負荷の悪い予測因子です.
科学分野:
- 心臓病学 心臓病学
- バイオマーカー バイオマーカー
- エピデミオロジー エピデミオロジー
背景:
- 高濃度のC反応性タンパク質 (CRP) は,心血管疾患のリスクの増加と関連しています.
- CRPレベルと既存の動脈硬化症の負担の間の関係については,あまり理解されていない.
研究 の 目的:
- C反応性タンパク質 (CRP) レベルと亜臨床性動脈硬化症の関連性を調査する.
- CRPが冠動脈結石化 (CAC) と大動脈斑塊の独立した予測因子であるかどうかを判断する.
主な方法:
- 30歳から65歳までの3373人の成人の多民族,人口ベースのサンプルであるダラス心臓研究が分析されました.
- 冠動脈カルシフィケーション (CAC) は,電子ビームCTスキャンを使用して測定されました.
- 大動脈のプラークはMRIを用いて評価された.
主要な成果:
- CACと大動脈のプラークを持つ被験者は,中位CRPレベルがより高かった.
- 男性では,より高いCACでCRPの増加の控えめな傾向が観察されました.
- CRPと動脈硬化症の測定値との関連は,従来の心血管リスク要因を調整した後に有意ではなかった.
結論:
- 高いCRPレベルは,亜臨床性動脈硬化症の有病率のわずかな増加と関連していました.
- この関連性は,従来の心血管疾患の危険因子とは無関係ではなかった.
- C反応性タンパク質 (CRP) は,動脈硬化症の負荷の悪い予測因子である.
関連する概念動画
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...